Found 40 matching trials
Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy NA The study aims to evaluate a modified antiplatelet therapy associated with ...
Show More Location
Universitätsklinikum
Learn More & Join Trial
Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry N/A The purpose of this observational registry was to compare the safety and ef...
Show More Location
Icahn School of Medicine at Mount Sinai
Learn More & Join Trial
A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY) PHASE4 In patients with heart attacks, the current standard of care is to restore ...
Show More Location
University of Ottawa Heart Institute
Learn More & Join Trial
Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I) NA This investigator-initiated, multicenter, open-label, randomized clinical t...
Show More Location
Beijing Luhe Hospital Capital Medical University
Learn More & Join Trial
Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months PHASE4 This study is testing different blood-thinning treatment strategies for peo...
Show More Location
Mater Private Network Dublin
Learn More & Join Trial
STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial NA This is a multicenter, open-label, randomized controlled study meant to com...
Show More Location
Fuwai Hospital, National Center for Cardiovascular Diseases,Chinese Academy of Medical Sciences
Learn More & Join Trial
Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF PHASE3 APERITIF is a prospective randomized open-label, blinded end-point (PROBE) ...
Show More Learn More & Join Trial
De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS PHASE3 High bleeding risk (HBR) patients, comprising up to 50% of those presenting...
Show More Location
Azienda Ospedaliera Universitaria Gaetano Martino
Learn More & Join Trial
STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT NA Primary percutaneous coronary intervention (PCI) is the preferred revascula...
Show More Location
Geneva University Hospitals
Learn More & Join Trial
DAPT Strategy in HBR Patients Undergoing Complex PCI Following ACS: Second-Phase Beta Testing of a Patients Decision Aid NA Among patients with acute coronary syndrome (ACS) treated with percutaneous...
Show More Location
Montreal Heart Institute
Learn More & Join Trial